Home » European Commission Enhances Ebola Outbreak Response with PCR Testing Support

European Commission Enhances Ebola Outbreak Response with PCR Testing Support

by republicoflibya.com

BRUSSELS, BELGIUM / RankWire.AI / – The European Commission has increased its Ebola response efforts by procuring €2.1 million worth of PCR tests to combat the Bundibugyo virus outbreak. The initiative involves open-platform testing kits that laboratories can integrate with their existing systems. The procurement process received backing from the European Health and Digital Executive Agency. Shipping is scheduled to commence in August, as health teams battle a significant outbreak centered in the Democratic Republic of the Congo and impacting neighboring regions.

European Commission adds PCR support for Ebola outbreak
PCR testing support strengthens the international response to Ebola in DR Congo.

The World Health Organization will facilitate the delivery of these tests via its Hub for Global Health Emergencies Logistics in Dubai. Following arrival, WHO will oversee distribution to locations engaged in the Ebola response. PCR testing enables labs to confirm infections and supports surveillance efforts around confirmed cases. Confirmed results are crucial for guiding patient treatment, isolation procedures, and contact tracing. This latest supply batch enhances laboratory capabilities during a period when authorities continue to monitor transmission across multiple provinces and health zones in the Democratic Republic of the Congo.

Previously, the European Commission allocated an additional €2.5 million for rapid molecular point-of-care tests and testing instruments. This equipment will aid the Africa Centres for Disease Control and Prevention in their regional outbreak management efforts. With these agreements, the total diagnostic support from Europe now reaches €4.6 million. They form part of a broader European aid package aimed at assisting countries affected by the Bundibugyo Ebola crisis, encompassing medical supplies, preparedness initiatives, and public health resources to strengthen responses in affected and neighboring areas.

Testing capabilities expand amid significant outbreak

As of August 12, WHO reported that the Democratic Republic of the Congo had confirmed 4,665 cases and recorded 2,184 deaths. Authorities detected infections across 54 health zones within six provinces, including Ituri, North Kivu, South Kivu, Haut-Uélé, Tshopo, and Bas-Uélé. WHO described this as the largest Ebola outbreak ever documented in the country. The organization also highlighted ongoing transmission within connected geographic clusters, which continues to place high demands on surveillance teams, laboratories, treatment centers, and local health services.

In its August update, WHO maintained a very high national risk assessment for the Democratic Republic of the Congo, with neighboring countries categorized as high risk and others as low. After its International Health Regulations Emergency Committee convened again on August 24, WHO issued revised temporary recommendations. These guidelines focus on surveillance, case detection, infection prevention, clinical management, and community engagement, in addition to public health measures related to mobility and mass gatherings during the ongoing response efforts.

European health aid now totals €493 million

The European Commission announced it has mobilized €493 million for emergency aid, vaccines, treatment, and health security measures across the Great Lakes and Uganda regions. European health agencies have also contributed to laboratory work, surveillance, and preparedness activities. According to the European Centre for Disease Prevention and Control, the risk to populations in Europe remains very low. Ebola primarily spreads through direct contact with infected bodily fluids, emphasizing the importance of rapid detection, safe clinical practices, and effective infection control measures to prevent further transmission.

The Bundibugyo virus outbreak continues to be classified as a public health emergency of international concern under WHO’s framework. Currently, there is no approved vaccine or specific treatment for Bundibugyo virus disease. Consequently, health authorities depend heavily on surveillance, swift diagnosis, isolation, clinical management, infection prevention, and contact monitoring. The new PCR testing supplies enhance these efforts. WHO, Africa CDC, and national health agencies are coordinating their activities to enable quick case detection and maintain essential public health measures within affected communities.

You may also like